Unknown

Dataset Information

0

Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Cancer with Heterogeneous Effects in the Tumor.


ABSTRACT: Innate inflammation promotes tumor development, although the role of innate inflammatory cytokines in established human tumors is unclear. Herein, we report clinical and translational results from a phase Ib trial testing whether IL1β blockade in human pancreatic cancer would alleviate myeloid immunosuppression and reveal antitumor T-cell responses to PD1 blockade. Patients with treatment-naïve advanced pancreatic ductal adenocarcinoma (n = 10) were treated with canakinumab, a high-affinity monoclonal human antiinterleukin-1β (IL1β), the PD1 blocking antibody spartalizumab, and gemcitabine/n(ab)paclitaxel. Analysis of paired peripheral blood from patients in the trial versus patients receiving multiagent chemotherapy showed a modest increase in HLA-DR+CD38+ activated CD8+ T cells and a decrease in circulating monocytic myeloid-derived suppressor cells (MDSC) by flow cytometry for patients in the trial but not in controls. Similarly, we used patient serum to differentiate monocytic MDSCs in vitro and showed that functional inhibition of T-cell proliferation was reduced when using on-treatment serum samples from patients in the trial but not when using serum from patients treated with chemotherapy alone. Within the tumor, we observed few changes in suppressive myeloid-cell populations or activated T cells as assessed by single-cell transcriptional profiling or multiplex immunofluorescence, although increases in CD8+ T cells suggest that improvements in the tumor immune microenvironment might be revealed by a larger study. Overall, the data indicate that exposure to PD1 and IL1β blockade induced a modest reactivation of peripheral CD8+ T cells and decreased circulating monocytic MDSCs; however, these changes did not lead to similarly uniform alterations in the tumor microenvironment.

SUBMITTER: Oberstein PE 

PROVIDER: S-EPMC11369625 | biostudies-literature | 2024 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Cancer with Heterogeneous Effects in the Tumor.

Oberstein Paul E PE   Dias Costa Andressa A   Kawaler Emily A EA   Cardot-Ruffino Victoire V   Rahma Osama E OE   Beri Nina N   Singh Harshabad H   Abrams Thomas A TA   Biller Leah H LH   Cleary James M JM   Enzinger Peter P   Huffman Brandon M BM   McCleary Nadine J NJ   Perez Kimberly J KJ   Rubinson Douglas A DA   Schlechter Benjamin L BL   Surana Rishi R   Yurgelun Matthew B MB   Wang S Jennifer SJ   Remland Joshua J   Brais Lauren K LK   Bollenrucher Naima N   Chang Eugena E   Ali Lestat R LR   Lenehan Patrick J PJ   Dolgalev Igor I   Werba Gregor G   Lima Cibelle C   Keheler C Elizabeth CE   Sullivan Keri M KM   Dougan Michael M   Hajdu Cristina C   Dajee Maya M   Pelletier Marc R MR   Nazeer Saloney S   Squires Matthew M   Bar-Sagi Dafna D   Wolpin Brian M BM   Nowak Jonathan A JA   Simeone Diane M DM   Dougan Stephanie K SK  

Cancer immunology research 20240901 9


Innate inflammation promotes tumor development, although the role of innate inflammatory cytokines in established human tumors is unclear. Herein, we report clinical and translational results from a phase Ib trial testing whether IL1β blockade in human pancreatic cancer would alleviate myeloid immunosuppression and reveal antitumor T-cell responses to PD1 blockade. Patients with treatment-naïve advanced pancreatic ductal adenocarcinoma (n = 10) were treated with canakinumab, a high-affinity mono  ...[more]

Similar Datasets

2024-07-01 | GSE267814 | GEO
| PRJNA1113170 | ENA
| S-EPMC8750272 | biostudies-literature
| S-EPMC5215252 | biostudies-literature
| S-EPMC9901023 | biostudies-literature
| S-EPMC2731790 | biostudies-literature
| S-EPMC8888617 | biostudies-literature
| S-EPMC5980384 | biostudies-literature
| S-EPMC7352890 | biostudies-literature
| S-EPMC8125420 | biostudies-literature